Novo Nordisk (Ozempic)

4780.706 - 4805.995 David Rosenthal

They're like, you know, I don't know that human insulin in and of itself is is all that much more effective. We're going to take a wait and see approach. We are going to invest in building up our recombinant DNA and genetic engineering capabilities because it's clear the whole industry is moving this way for production reasons, if nothing else. And Novo is doing this too in the background.